These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12823208)

  • 21. Inactivation of RUNX3 predicts poor prognosis in esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy.
    Shi M; Wang Z; Liu XY; Chen D
    Med Oncol; 2014 Dec; 31(12):309. PubMed ID: 25391920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis.
    Huang ZL; Lin ZR; Xiao YR; Cao X; Zhu LC; Zeng MS; Zhong Q; Wen ZS
    Oncotarget; 2015 Mar; 6(9):6850-61. PubMed ID: 25760075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PITX2: a promising predictive biomarker of patients' prognosis and chemoradioresistance in esophageal squamous cell carcinoma.
    Zhang JX; Tong ZT; Yang L; Wang F; Chai HP; Zhang F; Xie MR; Zhang AL; Wu LM; Hong H; Yin L; Wang H; Wang HY; Zhao Y
    Int J Cancer; 2013 Jun; 132(11):2567-77. PubMed ID: 23132660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of PDK1 associates with poor prognosis in esophageal squamous cell carcinoma with facilitating tumorigenicity in vitro.
    Yang Z; Wu Z; Liu T; Han L; Wang C; Yang B; Zheng F
    Med Oncol; 2014 Dec; 31(12):337. PubMed ID: 25416048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of Ku80 suggests poor prognosis of locally advanced esophageal squamous cell carcinoma patients.
    Wang S; Wang Z; Liu X; Liu Y; Jia Y
    World J Surg; 2015 Jul; 39(7):1773-81. PubMed ID: 25711486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant methylation of DACT1 and DACT2 are associated with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
    Guo YL; Shan BE; Guo W; Dong ZM; Zhou Z; Shen SP; Guo X; Liang J; Kuang G
    J Biomed Sci; 2017 Jan; 24(1):6. PubMed ID: 28077137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RICTOR expression in esophageal squamous cell carcinoma and its clinical significance.
    Jiang WJ; Feng RX; Liu JT; Fan LL; Wang H; Sun GP
    Med Oncol; 2017 Mar; 34(3):32. PubMed ID: 28132115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression status of CD44 and CD133 as a prognostic marker in esophageal squamous cell carcinoma treated with neoadjuvant chemotherapy followed by radical esophagectomy.
    Okamoto K; Ninomiya I; Ohbatake Y; Hirose A; Tsukada T; Nakanuma S; Sakai S; Kinoshita J; Makino I; Nakamura K; Hayashi H; Oyama K; Inokuchi M; Nakagawara H; Miyashita T; Hidehiro T; Takamura H; Fushida S; Ohta T
    Oncol Rep; 2016 Dec; 36(6):3333-3342. PubMed ID: 27748881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear translocation of HER-4/c-erbB-4 is significantly correlated with prognosis of esophageal squamous cell carcinoma.
    Xu S; Kitayama J; Yamashita H; Souma D; Nagawa H
    J Surg Oncol; 2008 Jan; 97(1):44-50. PubMed ID: 18000820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased expression of high-mobility group A2: A novel independent indicator of poor prognosis in patients with esophageal squamous cell carcinoma.
    Wei R; Shang Z; Leng J; Cui L
    J Cancer Res Ther; 2016; 12(4):1291-1297. PubMed ID: 28169242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of SATB2 expression in patients with esophageal squamous cell carcinoma.
    Geng GJ; Li N; Mi YJ; Yu XY; Luo XY; Gao J; Luo QC; Xie JD; Fa XE; Jiang J
    Int J Clin Exp Pathol; 2015; 8(1):423-31. PubMed ID: 25755730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
    Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
    J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.
    Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I
    Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. κ-Opioid receptor in the nucleus is a novel prognostic factor of esophageal squamous cell carcinoma.
    Zhang YF; Xu QX; Liao LD; Xu XE; Wu JY; Shen J; Wu ZY; Shen JH; Li EM; Xu LY
    Hum Pathol; 2013 Sep; 44(9):1756-65. PubMed ID: 23574786
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Twist1 is an independent prognostic factor of esophageal squamous cell carcinoma and associated with its epithelial-mesenchymal transition.
    Lee KW; Kim JH; Han S; Sung CO; Do IG; Ko YH; Um SH; Kim SH
    Ann Surg Oncol; 2012 Jan; 19(1):326-35. PubMed ID: 21732143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High expression of HLA-DQA1 predicts poor outcome in patients with esophageal squamous cell carcinoma in Northern China.
    Shen FF; Pan Y; Li JZ; Zhao F; Yang HJ; Li JK; Gao ZW; Su JF; Duan LJ; Lun SM; Zhang P; Tian LQ; Sun G; Huang D; Cao YT; Zhou FY
    Medicine (Baltimore); 2019 Feb; 98(8):e14454. PubMed ID: 30813145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.
    Xu F; Xu CZ; Gu J; Liu X; Liu R; Huang E; Yuan Y; Zhao G; Jiang J; Xu C; Chu Y; Lu C; Ge D
    Oncotarget; 2016 Jul; 7(28):43401-43411. PubMed ID: 27270324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathological and prognostic significance of FOXM1 expression in esophageal squamous cell carcinoma.
    Takata A; Takiguchi S; Okada K; Takahashi T; Kurokawa Y; Yamasaki M; Miyata H; Nakajima K; Mori M; Doki Y
    Anticancer Res; 2014 May; 34(5):2427-32. PubMed ID: 24778055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of p53 and RB proteins in squamous cell carcinoma of the esophagus: their relationship with clinicopathologic characteristics.
    Hashimoto N; Tachibana M; Dhar DK; Yoshimura H; Nagasue N
    Ann Surg Oncol; 1999; 6(5):489-94. PubMed ID: 10458688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical analysis of nuclear survivin expression in esophageal squamous cell carcinoma.
    Mega S; Miyamoto M; Li L; Kadoya M; Takahashi R; Hase R; Kaneko H; Shichinohe T; Kawarada Y; Itoh T; Morikawa T; Kondo S
    Dis Esophagus; 2006; 19(5):355-9. PubMed ID: 16984532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.